TWD 13.3
(-2.56%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 10.07 Million TWD | 0.0% |
2022 | - TWD | 0.0% |
2021 | - TWD | 0.0% |
2020 | - TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - TWD | 0.0% |
2024 Q2 | 5.99 Million TWD | 0.0% |
2023 Q3 | - TWD | 0.0% |
2023 FY | - TWD | 0.0% |
2023 Q4 | - TWD | 0.0% |
2023 Q2 | - TWD | 0.0% |
2023 Q1 | - TWD | 0.0% |
2022 FY | - TWD | 0.0% |
2022 Q4 | - TWD | 0.0% |
2022 Q3 | - TWD | 0.0% |
2021 FY | - TWD | 0.0% |
2020 FY | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 98.325% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 93.519% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | 76.112% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 99.081% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 99.37% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 99.081% |
Center Laboratories, Inc. | 269.22 Million TWD | 96.258% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | 86.709% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 95.694% |
InnoPharmax Inc. | 22.24 Million TWD | 54.709% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 92.742% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 95.364% |
DV Biomed Co., Ltd. | 96.51 Million TWD | 89.562% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | 92.055% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | 65.195% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 96.451% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | 91.296% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | 81.995% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | 91.491% |